Published in Telemedicine Business Week, February 14th, 2007
This trend article about Wayne State University, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Current study results from the report, "Phase I study of bryostatin 1 and gemcitabine," have been published. "Bryostatin 1 is a macrocyclic lactone with protein kinase C inhibitory activity. Gemcitabine is a nucleotide analogue with a broad spectrum of anticancer activity," scientists writing in the journal Clinical Cancer Research report.
"Bryostatin 1 enhanced the activity of antitumor agents including...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.